Viveo Health Revenue and Competitors
Estimated Revenue & Valuation
- Viveo Health's estimated annual revenue is currently $13.4M per year.
- Viveo Health's estimated revenue per employee is $243,000
Employee Data
- Viveo Health has 55 Employees.
- Viveo Health grew their employee count by 41% last year.
Viveo Health's People
Name | Title | Email/Phone |
---|
Viveo Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $58.5M | 197 | 8% | N/A | N/A |
#2 | $20.5M | 76 | 3% | N/A | N/A |
#3 | $202.5M | 600 | 26% | N/A | N/A |
#4 | $44.8M | 151 | 5% | N/A | N/A |
#5 | $34M | 126 | 4% | N/A | N/A |
#6 | $34.8M | 129 | 5% | N/A | N/A |
#7 | $42.8M | 144 | 31% | N/A | N/A |
#8 | $16.2M | 69 | -22% | $29.7M | N/A |
#9 | $2131.5M | 5639 | 10% | $9.3M | N/A |
#10 | $56.4M | 190 | 18% | N/A | N/A |
What Is Viveo Health?
Viveo Health: a fast, simple and secure e-health platform making healthcare accessible to everyone.
keywords:N/AN/A
Total Funding
55
Number of Employees
$13.4M
Revenue (est)
41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Viveo Health News
2022-04-19 - Viveo's Acquisition of Laboratorio de Insumos Farmacêuticos ...
Viveo is a healthcare technology platform that unites the entire health ecosystem (doctors, patients, clinics, labs) into a single solution, so...
2022-04-13 - Brazil's Viveo to acquire 3 medical products firms amid expansion push
Brazilian drug and medical products distributor Viveo has reached a deal to acquire three companies for a total 365.5 million reais ($77.86 million) as it...
2022-03-22 - Amid Russian Invasion, New Initiative Launches Free Telemedicine For
Ukrainians Under Siege
As the Russian invasion of Ukraine rages on, critical healthcare ... One such company, Viveo Health, an e-health platform based in Estonia,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.6M | 56 | 22% | N/A |
#2 | $7.3M | 58 | 12% | N/A |
#3 | $7.7M | 59 | -16% | N/A |
#4 | $17.3M | 59 | N/A | N/A |
#5 | $11.3M | 60 | 36% | N/A |